Clinical Trial Update: The Study of CM310 in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This document announces the completion of a Phase 2 clinical trial evaluating CM310 in adults with moderate-to-severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Moderate-to-severe Atopic Dermatitis | Phase 2 | Status: COMPLETED